在队列研究中使用案例-队列分析时,将生物标本汇集为有效的暴露评估.
Min Shi1, David M Umbach1, Clarice R Weinberg1
1Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA.
Environmental health perspectives
|December 24, 2024
概括
在案例和队列研究中,生物样本的聚合提高了统计能力,并保护了有价值的样本档案. 这种具有成本效益的策略增强了暴露与疾病相关性研究,同时最大限度地减少了样本耗尽.
科学领域:
- 流行病学 流行病学
- 生物统计学 生物统计学
- 环境健康 环境健康
背景情况:
- 前性队列研究对于确定暴露与疾病的联系至关重要.
- 案例队列研究利用子队列和事件案例进行生物样本分析.
- 生物标本聚合是一种节省成本和保存档案的策略,尚未对队列研究进行评估.
研究的目的:
- 开发和评估生物标本聚合策略,用于案例和队列分析.
- 使用聚合生物样本调查暴露和罕见疾病风险之间的关系.
主要方法:
- 制定了非子队列病例的聚合策略,按诊断时间分组.
- 按年龄分组子队列成员进入聚合集构造.
- 根据年龄和集合大小分层使用后勤回归,调整混因子;通过模拟和对姐妹研究数据的重新分析进行验证.
主要成果:
- 参数估计几乎没有偏见,具有表现良好的置信区间.
- 每个池最多8个标本的聚合导致了适度的功耗损失.
- 增加子队列大小和每个池的标本显著提高了功率和精度,同时减少了测试数量.
结论:
- 生物标本的聚合是个可行的策略,用于病例队列分析.
- 它增强了统计能力,保存了不可替代的生物标本档案,并降低了成本.
- 流行病学家应该考虑在队列研究中将生物标本用于暴露疾病研究.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
101
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
101
01:20Comparing the Survival Analysis of Two or More Groups
83
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
83